We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+9.19%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$41B
AUM Growth
+$3.8B
(+10%)
Cap. Flow
+$1.3B
Cap. Flow
% of AUM
3.16%
Top 10 Holdings %
Top 10 Hldgs %
10.03%
Holding
2,541
New
203
Increased
773
Reduced
1,202
Closed
335
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$248M |
| 2 |
United Parcel Service
UPS
|
+$242M |
| 3 |
Las Vegas Sands
LVS
|
+$215M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
PepsiCo
PEP
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$291M |
| 2 |
IBM
IBM
|
+$164M |
| 3 |
General Mills
GIS
|
+$161M |
| 4 |
Burlington
BURL
|
+$155M |
| 5 |
Netflix
NFLX
|
+$143M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Consumer Discretionary | 16.16% |
| 3 | Healthcare | 12.61% |
| 4 | Industrials | 11.92% |
| 5 | Financials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Scholastic
SCHL
$752M
| $1.61M | ﹤0.01% |
34,407
+2,700
| +9% | +$116K |
|
|
ECYT
1327
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $1.6M | ﹤0.01% |
90,300
+40,000
| +80% | +$687K |
|
|
TBI
1328
Trueblue
TBI
$237M
| $1.6M | ﹤0.01% |
61,527
-4,700
| -7% | -$130K |
|
|
WBC
1329
DELISTED
WABCO HOLDINGS INC.
WBC
| $1.6M | ﹤0.01% |
13,589
-100,600
| -88% | -$12.1M |
|
1330
Cass Information Systems
CASS
$705M
| $1.6M | ﹤0.01% |
29,526
-11,160
| -27% | -$647K |
|
|
HTLF
1331
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.6M | ﹤0.01% |
27,500
-196
| -0.7% | -$11.6K |
|
1332
Travere Therapeutics
TVTX
$5.27B
| $1.59M | ﹤0.01% |
55,500
-22,900
| -29% | -$655K |
|
|
GLUU
1333
DELISTED
Glu Mobile Inc.
GLUU
| $1.59M | ﹤0.01% |
213,902
+76,300
| +55% | +$514K |
|
1334
Magnite
MGNI
$2.73B
| $1.59M | ﹤0.01% |
440,625
-158,200
| -26% | -$559K |
|
1335
Axogen
AXGN
$2.19B
| $1.58M | ﹤0.01% |
43,000
-51,900
| -55% | -$2.27M |
|
1336
Oaktree Specialty Lending
OCSL
$1.04B
| $1.58M | ﹤0.01% |
105,926
+4,433
| +4% | +$65.4K |
|
1337
TriCo Bancshares
TCBK
$1.84B
| $1.58M | ﹤0.01% |
40,804
+390
| +1% | +$15.1K |
|
1338
Westamerica Bancorp
WABC
$1.38B
| $1.57M | ﹤0.01% |
26,100
+500
| +2% | +$30.7K |
|
|
VNTR
1339
DELISTED
Venator Materials PLC
VNTR
| $1.57M | ﹤0.01% |
174,100
+102,100
| +142% | +$1.32M |
|
1340
Acco Brands
ACCO
$381M
| $1.56M | ﹤0.01% |
138,091
-37,800
| -21% | -$485K |
|
|
FNSR
1341
DELISTED
Finisar Corp
FNSR
| $1.56M | ﹤0.01% |
81,909
-318,000
| -80% | -$5.91M |
|
1342
HealthEquity
HQY
$8.28B
| $1.56M | ﹤0.01% |
16,500
+10,800
| +189% | +$930K |
|
1343
Ecopetrol
EC
$32.5B
| $1.56M | ﹤0.01% |
57,800
+14,800
| +34% | +$327K |
|
|
KBAL
1344
DELISTED
Kimball International
KBAL
| $1.55M | ﹤0.01% |
92,857
-2,400
| -3% | -$40.8K |
|
1345
Resources Connection
RGP
$133M
| $1.55M | ﹤0.01% |
93,484
-6,200
| -6% | -$101K |
|
|
CAI
1346
DELISTED
CAI International, Inc.
CAI
| $1.54M | ﹤0.01% |
67,509
-26,900
| -28% | -$657K |
|
|
TOWR
1347
DELISTED
Tower International, Inc.
TOWR
| $1.53M | ﹤0.01% |
50,712
-49,500
| -49% | -$1.61M |
|
|
LMNX
1348
DELISTED
Luminex Corp
LMNX
| $1.52M | ﹤0.01% |
50,226
-119,100
| -70% | -$3.57M |
|
|
LPNT
1349
DELISTED
LifePoint Health, Inc.
LPNT
| $1.52M | ﹤0.01% |
23,608
-27,000
| -53% | -$1.65M |
|
1350
BioCryst Pharmaceuticals
BCRX
$2.43B
| $1.51M | ﹤0.01% |
198,212
+29,000
| +17% | +$195K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2018 Portfolio in Review
As of Q3 2018, Two Sigma Advisers held 2,541 positions worth $41B, up 10% from $37.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Two Sigma Advisers deployed $1.3B of net new capital in Q3 2018, opening 203 new positions and adding to 773 existing holdings. Its largest new stake was Phillips 66: 902,917 shares worth $102M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $291M trimmed.
- Two Sigma Advisers's largest Q3 2018 buy was Phillips 66: 902,917 shares worth $102M.
- Two Sigma Advisers added most to Intuit in Q3 2018, an estimated $248M increase.
- Two Sigma Advisers's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $291M.
- Two Sigma Advisers fully exited Burlington in Q3 2018, selling an estimated $155M.
- Two Sigma Advisers's ten largest holdings make up 10% of its $41B portfolio in Q3 2018.
- Two Sigma Advisers opened 203 new positions and closed 335 in Q3 2018.
- Two Sigma Advisers's portfolio value rose 10% quarter-over-quarter to $41B.
Based on Two Sigma Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.